Joel D. Sendek
Directeur Financier/CFO chez Forward Pharma USA, LLC
Profil
Joel D.
Sendek is currently the Chief Financial Officer at Forward Pharma USA, LLC.
He previously worked as the Managing Director-Healthcare Equity Research at Stifel Financial Corp.
from 2012 to 2014, Senior Director at Progenics Pharmaceuticals, Inc. from 1992 to 1996, Managing Director at Lazard, Inc., Managing Director & Head of Equity Research at Stifel, Nicolaus & Co., Inc. from 2011 to 2014, Managing Director & Senior Analyst at FM Partners Holdings LLC from 2000 to 2011, Principal at Goldman Sachs & Co. LLC in 1991, and Analyst at Gerard Klauer Mattison & Co., Inc. from 1997 to 1999.
He also served as the CFO & Principal Accounting Officer at Forward Pharma A from 2014 to 2017 and CFO, Treasurer & Chief Accounting Officer at Spero Therapeutics, Inc. from 2017 to 2019.
Mr. Sendek received his undergraduate degree from Rice University in 1989.
Postes actifs de Joel D. Sendek
| Sociétés | Poste | Début |
|---|---|---|
| Forward Pharma USA, LLC | Directeur Financier/CFO | - |
Anciens postes connus de Joel D. Sendek
| Sociétés | Poste | Fin |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Directeur Financier/CFO | 08/11/2019 |
| FORWARD PHARMA A/S | Directeur Financier/CFO | 30/04/2017 |
Stifel, Nicolaus & Co., Inc.
 Stifel, Nicolaus & Co., Inc. Investment ManagersFinance Stifel, Nicolaus & Co., Inc. (Stifel) is a dual-registered broker-dealer and investment adviser headquartered in St. Louis, Missouri. Founded in 1890, the firm is a subsidiary of Stifel Financial Corp. (NYSE: SF), a financial service holding company. Stifel provides full-service brokerage and investment advisory services to individuals and their families, institutions and businesses, and financial advisors. | Analyst-Equity | 01/07/2014 |
| STIFEL FINANCIAL CORP. | Directeur Technique/Scientifique/R&D | 01/07/2014 |
FM Partners Holdings LLC
 FM Partners Holdings LLC Investment Banks/BrokersFinance FM Partners Holdings LLC is a broker/dealer headquartered in New York City. The firm was formerly known as Lazard Capital Markets LLC.. They are a subsidiary of LFCM Holdings LLC. | Analyst-Equity | 31/12/2011 |
Formation de Joel D. Sendek
| Rice University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| STIFEL FINANCIAL CORP. | Finance |
| LAZARD, INC. | Finance |
| SPERO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Stifel, Nicolaus & Co., Inc.
Stifel, Nicolaus & Co., Inc. Investment ManagersFinance Stifel, Nicolaus & Co., Inc. (Stifel) is a dual-registered broker-dealer and investment adviser headquartered in St. Louis, Missouri. Founded in 1890, the firm is a subsidiary of Stifel Financial Corp. (NYSE: SF), a financial service holding company. Stifel provides full-service brokerage and investment advisory services to individuals and their families, institutions and businesses, and financial advisors. | Finance |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |
| Gerard Klauer Mattison & Co., Inc. | Finance |
FM Partners Holdings LLC
FM Partners Holdings LLC Investment Banks/BrokersFinance FM Partners Holdings LLC is a broker/dealer headquartered in New York City. The firm was formerly known as Lazard Capital Markets LLC.. They are a subsidiary of LFCM Holdings LLC. | Finance |
Forward Pharma A/S
 Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 2005 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Forward Pharma USA, LLC |
